For patients on other anticoagulants, different reversal agents are required. For instance, andexanet alfa is used to reverse the effects of factor Xa inhibitors, while prothrombin complex concentrates may be used for warfarin reversal. However, idarucizumab remains the only specific reversal agent for dabigatran, highlighting its unique role in managing anticoagulation therapy.
